Skip to main content
. 2020 Oct 15;56(4):2000151. doi: 10.1183/13993003.00151-2020

FIGURE 2.

FIGURE 2

Asthma exacerbation rates in the pre-mepolizumab treatment period (365 days prior to enrolment plus any exacerbations starting during run-in) and 12-month follow-up period. BEC: blood eosinophil count. The n-value indicates the number of patients.